In the latest installment of our “Hope Behind the Headlines” series, we look at the SARS-CoV-2 vaccine trials that have been progressing successfully, and at
Read moreA machine learning tool that can assess the credibility of research could shorten the review period for scientific studies and, potentially, help identify the most
Read moreDoctors have published a correspondence article warning that untested COVID-19 treatments may do more harm than good. Stay informed with live updates on the current
Read moreA survey of 562 people in the United States helps reveal the emotional impact of the pandemic, suggesting that many turn to substances such as
Read moreAt the end of March, we asked our medical experts what they wished the public knew about SARS-CoV-2 and COVID-19. The answers were insightful. Now,
Read moreA new study has reassured medical professionals and patients alike that common drugs for lowering blood pressure are not linked to an increased risk of
Read moreA new study suggests that SARS-CoV-2, the virus that causes COVID-19, is most likely to target specific cells present in the nasal passages, lungs, and
Read moreTests have confirmed that two hand sanitizer formulations recommended by the World Health Organization (WHO) inactivate the virus that causes coronavirus disease 19 (COVID-19). The
Read moreA new study in cell cultures suggests that ivermectin, an existing antiparasitic drug, is able to eliminate SARS-CoV-2 within 48 hours. However, whether this approach
Read moreExperimental Ebola drug remdesivir could stop SARS-CoV-2 from replicating by acting on a key enzyme, according to a new study from the University of Alberta.
Read more